Meda introduces Xerese in US
Earlier in February 2010, Meda has got exclusive license for marketing, selling and distributing Xerese in the US, Canada and Mexico for the treatment of cold sores (herpes
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.